Cargando…
Novel Pyoverdine Inhibitors Mitigate Pseudomonas aeruginosa Pathogenesis
Pseudomonas aeruginosa is a clinically important pathogen that causes a variety of infections, including urinary, respiratory, and other soft-tissue infections, particularly in hospitalized patients with immune defects, cystic fibrosis, or significant burns. Antimicrobial resistance is a substantial...
Autores principales: | Kirienko, Daniel R., Kang, Donghoon, Kirienko, Natalia V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333909/ https://www.ncbi.nlm.nih.gov/pubmed/30687293 http://dx.doi.org/10.3389/fmicb.2018.03317 |
Ejemplares similares
-
High-Throughput Genetic Screen Reveals that Early Attachment and Biofilm Formation Are Necessary for Full Pyoverdine Production by Pseudomonas aeruginosa
por: Kang, Donghoon, et al.
Publicado: (2017) -
Pyoverdine Inhibitors and Gallium Nitrate Synergistically Affect Pseudomonas aeruginosa
por: Kang, Donghoon, et al.
Publicado: (2021) -
Pyoverdine-Dependent Virulence of Pseudomonas aeruginosa Isolates From Cystic Fibrosis Patients
por: Kang, Donghoon, et al.
Publicado: (2019) -
A High-Content, Phenotypic Screen Identifies Fluorouridine as an Inhibitor of Pyoverdine Biosynthesis and Pseudomonas aeruginosa Virulence
por: Kirienko, Daniel R., et al.
Publicado: (2016) -
Pyoverdine, a siderophore from Pseudomonas aeruginosa, translocates into C. elegans, removes iron, and activates a distinct host response
por: Kang, Donghoon, et al.
Publicado: (2018)